Normal transferrin patterns in congenital disorders of glycosylation with Golgi homeostasis disruption: apolipoprotein C-III at the rescue

•Inherited deficiencies in Golgi proton pump or trafficking proteins can be associated with congenital disorders of glycosylation (CDG).•The gold standard for CDG screening is transferrin isoelectric focusing.•CDG with Golgi homeostasis disruption are associated with abnormal glycosylation profiles...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinica chimica acta 2021-08, Vol.519, p.285-290
Hauptverfasser: Raynor, Alexandre, Vincent-Delorme, Catherine, Alaix, Anne-Sophie, Cholet, Sophie, Dupré, Thierry, Vuillaumier-Barrot, Sandrine, Fenaille, François, Besmond, Claude, Bruneel, Arnaud
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Inherited deficiencies in Golgi proton pump or trafficking proteins can be associated with congenital disorders of glycosylation (CDG).•The gold standard for CDG screening is transferrin isoelectric focusing.•CDG with Golgi homeostasis disruption are associated with abnormal glycosylation profiles of apolipoprotein C-III (apoC-III).•We report three CDG cases with Golgi homeostasis disruption (ATP6V0A2-CDG and COG4-CDG) and normal transferrin glycoforms patterns.•We show the potential of two-dimensional electrophoresis of apoC-III in diagnosing this type of CDG. We identified three cases of congenital disorders of glycosylation (CDG) with Golgi homeostasis disruption, one ATP6V0A2-CDG and two COG4-CDG, with normal transferrin screening analyses. Patient 1 (P1) presented at birth with cutis laxa. Patient 2 (P2) and patient 3 (P3) are adult siblings and presented with severe symptoms evocative of inborn errors of metabolism. Targeted gene sequencing in P1 revealed pathogenic ATP6V0A2 variants, shared by her affected older brother. In P2 and P3, whole exome sequencing revealed a homozygous COG4 variant of unknown significance. In all affected individuals, transferrin analysis was normal. Mass-spectrometry based serum N-glycome analysis and two-dimensional electrophoresis (2-DE) of haptoglobin and of mucin core 1 O-glycosylated apolipoprotein C-III (apoC-III) were performed. All results of second-line N-glycosylation analyses were initially normal. However, apoC-III 2-DE revealed characteristic “apoC-III1” pattern in P1 and specific “apoC-III0” patterns in P2 and P3. In P2 and P3, this allowed reclassifying the variant as likely pathogenic according to ACMG guidelines. These cases highlight the existence of normal transferrin patterns in CDG with Golgi homeostasis disruption, putting the clinicians at risk of misdiagnosing patients. Furthermore, they show the potential of apoC-III 2-DE in diagnosing this type of CDG, with highly specific patterns in COG-CDG.
ISSN:0009-8981
1873-3492
DOI:10.1016/j.cca.2021.05.016